Pharmaceutical Technology Editors

Constantia Flexibles acquired a flexible packaging business from Lamp San Prospero SPA.

Xellia added laboratory space and personnel in Zagreb, Croatia to work on anti-infective products that combat the antimicrobial resistance problem.

Tosoh Bioscience adds TOYOPEARL Sulfate-650F, a strong cation exchange resin that exhibits high salt tolerance, to its process media product line.

Bio-Rad Laboratories’ Nuvia IMAC Resin, an immobilized metal affinity chromatography resin, is optimized for use from laboratory-scale through pilot studies to process-scale manufacturing.

Pharmaceutical Technology Europe will be exhibiting at CPhI Worldwide at Stand 3G98.

The Phase III trial examined guselkumab compared with a placebo and Humira at treating moderate-to-severe plaque psoriasis.

Allergan entered into a licensing agreement with AstraZeneca for MEDI2070, an anti-IL-23 monoclonal antibody in phase IIB development for the treatment of patients with moderate-to-severe Crohn’s disease.

The company invested in a new cGMP facility located in Berlin, Germany.

The new company will focus on R&D of cancer treatments.

The hospital received a five-year $5 million grant from CDC to survey for communicable diseases in children and evaluate vaccine effectiveness.

ViraTherapeutics will develop its VSV-GP therapy alone and in combination with other therapies.

FDA’s Center for Drug Evaluation and Research provides an update on its safety initiatives.

he guidance addresses the good manufacturing practice for managing quality in APIs.

The company is voluntarily recalling all unexpired lots of 50-mm, 0.2-micron filters.

EDQM and the Japanese Pharmacopoeia will improve the sharing of information on therapeutic products that are common in both Europe and Japan.

PaizaBio will add aseptic injectable production capacity in Hangzhou, China.

Tapemark, a full-service CDMO specializing in transdermal, oral thin film, and topical drug-delivery technologies, is exhibiting at CPhI.

Could grading finished-drug manufacturers on their quality and efficiency lead to greater transparency, improve quality and reduce drug shortages?

The agency appealed two interim orders to suspend the release of documents requested by third parties.

Ravi Limaye gives an overview of the biosimilar industry and projects for 2020.

Gil Roth gives an overview and outlook for the CDMO industry in 2016.

Alan Sheppard, Principal, Global Generics at IMS Health and CPhI expert panel member, discusses generic medicine opportunities in the 2016 CPhI Annual Industry Report.

Three-dimensional (3D) printing, which is a type of additive manufacturing (AM), enables fabrication of specialty drugs and medical devices, said Emil Ciurczak, Doramaxx Consulting and CPhI expert panel member, in the 2016 CPhI Annual Industry Report.

The CDMO has acquired a new building to expand its high-containment manufacturing and development operations.

Sharp will present alongside Tracelink, Systech, Covectra, and Domino during CPhI Worldwide.

Mettler Toledo launched the Rainin BenchSmart 96, a new liquid handling platform.

Containing costs and improving compliance will be crucial to ensuring the growth of generic pharmaceuticals in the future, says Dilip Shah, CEO of Vision Consulting Group, in CPhI’s 2016 Annual Report, which will be formally issued at CPhI 2016 in Barcelona.

STERIS launched the Reliance 300XLS Laboratory Glassware Washer, adding to the company’s line of glassware and plasticware washing systems.

Onset expanded its product line for pharmaceutical cold-chain management with the launch two new products.

The next decade of drug development will depend on better ways of storing, using, and analyzing data, says CPhI advisor Bikash Chatterjee, president and chief science officer of Pharmatech Associates. But each of the following must be optimized: volume, variety, velocity, veracity, and value.